Apyx Medical Corp Proceeds from (Repayments of) Long-term Debt and Capital Securities
Apyx Medical Corp (APYX) reported Proceeds from (Repayments of) Long-term Debt and Capital Securities of $0 for the 3-month period ending 2019-03-31, per its 10-Q/A filed 2020-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities · last filed 2020-05-08
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for the quarter ending 2019-03-31 was $0.00.
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for the quarter ending 2018-12-31 was $0.00.
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for the quarter ending 2018-09-30 was -$2.57M.
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for the quarter ending 2018-06-30 was -$60.00K.
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for fiscal 2018 was -$2.69M.
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for fiscal 2017 was -$239.00K.
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for fiscal 2016 was -$240.00K.
- Apyx Medical Corp proceeds from (repayments of) long-term debt and capital securities for fiscal 2015 was -$239.00K, a 107.53% decline from fiscal 2014.
| Period end | Proceeds from (Repayments of) Long-term Debt and Capital Securities 3 month | Proceeds from (Repayments of) Long-term Debt and Capital Securities 6 month | Proceeds from (Repayments of) Long-term Debt and Capital Securities 9 month | Proceeds from (Repayments of) Long-term Debt and Capital Securities 12 month |
|---|---|---|---|---|
| 2019-03-31 | $0.00 10-Q/A · filed 2020-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-05-08 | -$2.57M derived: sum of 3 quarters · filed 2020-05-08 | -$2.63M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-03-14 | -$2.57M derived: sum of 2 quarters · filed 2020-05-08 | -$2.63M derived: sum of 3 quarters · filed 2020-05-08 | -$2.69M 10-K · filed 2019-03-14 |
| 2018-09-30 | -$2.57M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-05-08 | -$2.63M derived: sum of 2 quarters · filed 2020-05-08 | -$2.69M 10-Q/A · filed 2020-05-08 | -$2.75M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-01 | -$120.00K 10-Q · filed 2018-08-01 | -$180.00K derived: sum of 3 quarters · filed 2020-05-08 | -$240.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-03-31 | -$60.00K 10-Q/A · filed 2020-05-08 | -$120.00K derived: sum of 2 quarters · filed 2020-05-08 | -$180.00K derived: sum of 3 quarters · filed 2020-05-08 | -$240.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2017-12-31 | -$60.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-03-14 | -$120.00K derived: sum of 2 quarters · filed 2020-05-08 | -$180.00K derived: sum of 3 quarters · filed 2020-05-08 | -$239.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | -$60.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-05-08 | -$120.00K derived: sum of 2 quarters · filed 2020-05-08 | -$179.00K 10-Q/A · filed 2020-05-08 | -$239.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2017-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$119.00K 10-Q · filed 2018-08-01 | -$179.00K derived: sum of 3 quarters · filed 2019-03-14 | -$239.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | -$59.00K 10-Q · filed 2018-05-15 | -$119.00K derived: sum of 2 quarters · filed 2019-03-14 | -$179.00K derived: sum of 3 quarters · filed 2019-03-14 | -$238.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$120.00K derived: sum of 2 quarters · filed 2019-03-14 | -$179.00K derived: sum of 3 quarters · filed 2019-03-14 | -$240.00K 10-K · filed 2019-03-14 |
| 2016-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$119.00K derived: sum of 2 quarters · filed 2017-11-03 | -$180.00K 10-Q · filed 2017-11-03 | |
| 2016-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$120.00K 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | -$61.00K 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | -$239.00K 10-K · filed 2018-03-13 | |||
| 2014-12-31 | $3.17M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |